| 000 | 01554 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512210608.0 | ||
| 264 | 0 | _c19880314 | |
| 008 | 198803s 0 0 eng d | ||
| 022 | _a0730-8485 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKreutzer, D L | |
| 245 | 0 | 0 |
_aCharacterization of the anaphylatoxin inactivator and chemotactic factor inactivator activities during cardiopulmonary bypass. _h[electronic resource] |
| 260 |
_bJournal of experimental pathology _c1984 |
||
| 300 |
_a183-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 |
_aAnaphylatoxins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCardiopulmonary Bypass _xadverse effects |
| 650 | 0 | 4 |
_aChemotactic Factors _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aComplement C3 _xmetabolism |
| 650 | 0 | 4 | _aComplement C3a |
| 650 | 0 | 4 |
_aComplement C5 _xmetabolism |
| 650 | 0 | 4 | _aComplement C5a |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aKinetics |
| 650 | 0 | 4 |
_aLung _xblood supply |
| 650 | 0 | 4 |
_aLysine Carboxypeptidase _xmetabolism |
| 650 | 0 | 4 |
_aPeptides _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPulmonary Edema _xetiology |
| 650 | 0 | 4 |
_aRespiration Disorders _xetiology |
| 650 | 0 | 4 |
_aVascular Diseases _xetiology |
| 700 | 1 | _aMcCormick, J R | |
| 700 | 1 | _aDespins, A | |
| 700 | 1 | _aMoore, M | |
| 700 | 1 | _aRousou, J H | |
| 700 | 1 | _aDobbs, W | |
| 700 | 1 | _aEngleman, R N | |
| 773 | 0 |
_tJournal of experimental pathology _gvol. 1 _gno. 3 _gp. 183-7 |
|
| 999 |
_c6336222 _d6336222 |
||